Rowland Carmichael Advisors’s Pfizer PFE Stock Holding History

Rowland Carmichael Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$302K	Sell	8,205 -2,551	-24%	-$93.6K	0.1%	228
2020 Q3	$375K	Buy	10,756 +82	+0.8%	+$2.88K	0.15%	166
2020 Q2	$331K	Buy	10,674 +44	+0.4%	+$1.5K	0.14%	178
2020 Q1	$329K	Buy	10,630 +2,077	+24%	+$70.8K	0.17%	155
2019 Q4	$318K	Hold	8,553	–	–	0.11%	214
2019 Q3	$292K	Buy	8,553 +587	+7%	+$21.3K	0.1%	221
2019 Q2	$327K	Hold	7,966	–	–	0.11%	191
2019 Q1	$321K	Hold	7,966	–	–	0.12%	185
2018 Q4	$330K	Hold	7,966	–	–	0.15%	165
2018 Q3	$333K	Hold	7,966	–	–	0.13%	184
2018 Q2	$274K	Hold	7,966	–	–	0.12%	208
2018 Q1	$268K	Hold	7,966	–	–	0.15%	193
2017 Q4	$274K	Sell	7,966 -721	-8%	-$24.6K	0.14%	195
2017 Q3	$294K	Buy	8,687 +721	+9%	+$23.2K	0.16%	170
2017 Q2	$254K	Sell	7,966 -304	-4%	-$9.59K	0.15%	184
2017 Q1	$268K	Buy	8,270 +86	+1%	+$2.71K	0.16%	168
2016 Q4	$252K	Sell	8,184 -656	-7%	-$20K	0.15%	188
2016 Q3	$284K	Sell	8,840 -11	-0.1%	-$368	0.18%	166
2016 Q2	$296K	Buy	8,851 +1,439	+19%	+$45.9K	0.19%	157
2016 Q1	$208K	Buy	+7,412	New	+$212K	0.19%	129

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Rowland Carmichael Advisors's PFE Position: Q4 2020 in Review

Rowland Carmichael Advisors reduced its Pfizer (PFE) stake by 24% in Q4 2020, selling an estimated $93.6K and leaving 8,205 shares worth $302K. The position accounts for 0.1% of the portfolio, ranked #228.

Rowland Carmichael Advisors first reported a position in PFE in Q1 2016 and has held it in 20 quarters since. The position peaked at $375K in Q3 2020. 2,674 funds tracked by Wall St. Rank hold PFE as of Q4 2020.

Rowland Carmichael Advisors held 8,205 shares of Pfizer worth $302K as of Q4 2020.
Rowland Carmichael Advisors sold 2,551 Pfizer shares in Q4 2020, an estimated $93.6K.
Pfizer made up 0.1% of Rowland Carmichael Advisors's portfolio in Q4 2020, its #228 holding.
Rowland Carmichael Advisors first reported a position in Pfizer in Q1 2016 and has held it in 20 quarters since.
Rowland Carmichael Advisors's Pfizer position peaked at $375K in Q3 2020.
2,674 funds tracked by Wall St. Rank held Pfizer as of Q4 2020.

Based on Rowland Carmichael Advisors's 13F filing for Q4 2020, filed 15 Jan 2021.